Literature DB >> 5123910

Aluminium in bone from patients with renal failure.

V Parsons, C Davies, C Goode, C Ogg, J Siddiqui.   

Abstract

Some samples of bone from patients with renal failure contained more aluminium than others, and the concentration tended to be highest in patients who had been uraemic or on dialysis longest. The significance of the association of raised concentrations of aluminium in bone with renal failure is discussed.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5123910      PMCID： PMC1799594          DOI： 10.1136/bmj.4.5782.273

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  6 in total

1.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION. I. LIGHT MICROSCOPIC OBSERVATIONS.

Authors:  I KLATZO; H WISNIEWSKI; E STREICHER
Journal:  J Neuropathol Exp Neurol       Date:  1965-04       Impact factor: 3.685

2.  Hyperaluminaemia from aluminum resins in renal failure.

Authors:  G M Berlyne; J Ben-Ari; D Pest; J Weinberger; M Stern; R Levine; G R Gilmore
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

3.  Neurofibrillary spheroids induced by aluminum phosphate in dorsal root ganglia neurons in vitro.

Authors:  F J Seil; P W Lampert; I Klatzo
Journal:  J Neuropathol Exp Neurol       Date:  1969-01       Impact factor: 3.685

4.  Treatment of calcinosis universalis with aluminium hydroxide.

Authors:  J R Nassim; C K Connolly
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

5.  The effect of polyvalent metal ions on the stability of a buffer system for calcification in vitro.

Authors:  B N Bachra; G A van Harskamp
Journal:  Calcif Tissue Res       Date:  1970

6.  Hyperaluminaemia form aluminium resins.

Authors:  O M Wrong; J D Swales
Journal:  Lancet       Date:  1970-11-28       Impact factor: 79.321
  6 in total
  17 in total

1.  [The analyses of aluminum in serum and urine for monitoring of exposed persons (author's transl)].

Authors:  H Valentin; P Preusser; K H Schaller
Journal:  Int Arch Occup Environ Health       Date:  1976-10-21       Impact factor: 3.015

2.  Aluminium and lead abnormalities in children on haemodialysis: relationship with some medications.

Authors:  Manal F Elshamaa; Samar Sabry; Inas Mokhtar; Gamila S El-Saaid; Mona Raafat; Dalia A Abd-El Haleem
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

3.  Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.

Authors:  H A Ellis; J H McCarthy; J Herrington
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

4.  Aluminium containers.

Authors:  S Shaw
Journal:  Br Med J       Date:  1972-04-15

5.  Haemodialysis related osteomalacia: a staining method to demonstrate aluminium.

Authors:  M R Buchanan; B U Ihle; C M Dunn
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

Review 6.  [Aluminum toxicity].

Authors:  H V Henning
Journal:  Klin Wochenschr       Date:  1989-12-15

7.  Inhibition of mineralization of glutaraldehyde-pretreated bovine pericardium by AlCl3. Mechanisms and comparisons with FeCl3, LaCl3, and Ga(NO3)3 in rat subdermal model studies.

Authors:  C L Webb; F J Schoen; W E Flowers; A C Alfrey; C Horton; R J Levy
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

8.  Aluminum in Saudi children.

Authors:  I al-Saleh; N Shinwari
Journal:  Biometals       Date:  1996-10       Impact factor: 2.949

9.  Localisation of aluminium by histochemical and electron probe x-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy.

Authors:  P S Smith; J McClure
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

10.  Effects of parathyroidectomy on tissue calcium, phosphorus, magnesium, and copper concentrations in aluminum-loaded uremic rats.

Authors:  S Vukicević; A Stavljenić; T Boll; G Vujicić; C Degenhardt; M Cervar; B Krempien
Journal:  Biol Trace Elem Res       Date:  1989-10       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.